Skip to content

Clinical trials

Small Cell Lung Carcinoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Country / region: Canada Clear all

92 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20033
20052
20061
20074
20085
20091
20103
20112
20122
20131
20144
20153
20166
20178
20185
20207
20219
20223
20233
20242
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Active, not recruiting15
Recruiting11
Terminated9
Not yet recruiting2
Unknown status2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AHS Cancer Control Alberta7
AbbVie6
AstraZeneca5
Bristol-Myers Squibb5
British Columbia Cancer Agency5
Merck Sharp & Dohme LLC5
Alliance for Clinical Trials in Oncology4
Amgen4
Pfizer4
GlaxoSmithKline3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma92
Lung Neoplasms26
Carcinoma, Non-Small-Cell Lung21
Breast Neoplasms10
Neoplasms8
Triple Negative Breast Neoplasms8
Melanoma7
Endometrial Neoplasms6
Head and Neck Neoplasms6
Carcinoma, Merkel Cell5

Trials

Showing 76 to 92 of 92. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.